A

AsclepiX Therapeutics, Inc.

13 employees

AsclepiX Therapeutics is a biotech company that develops novel therapeutics to revolutionize the treatment of retinal diseases and cancer.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Diagnostics
therapeutics
biotechnology
Health Care
Therapeutics
peptides
ophthalmology
macular edema
age-related macular degeneration
oncology

Date founded

2011

Funding rounds raised

Total raised

$35M

from 4 investors over 4 rounds

A

AsclepiX Therapeutics, Inc. raised $35M on June 24, 2020

Investors: Rapha Capital Management, LLC and Perceptive Advisors

A

AsclepiX Therapeutics, Inc. raised $5M on November 13, 2018

Investors: Rapha Capital Management, LLC and Salem Partners LLC

FAQ